{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:52:14Z","timestamp":1792637534921,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,30]],"date-time":"2014-11-30T00:00:00Z","timestamp":1417305600000},"content-version":"vor","delay-in-days":2100,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1111\/j.1469-0691.2008.02663.x","type":"journal-article","created":{"date-parts":[[2009,1,22]],"date-time":"2009-01-22T17:21:02Z","timestamp":1232644862000},"page":"238-244","source":"Crossref","is-referenced-by-count":71,"title":["Antibiotic susceptibility among Staphylococcus epidermidis isolated from prosthetic joint infections with special focus on rifampicin and variability of the rpoB gene"],"prefix":"10.1016","volume":"15","author":[{"given":"B.","family":"Hellmark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Unemo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5.","family":"Nilsdotter-Augustinsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"S\u00f6derquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2008.02663.x_bib1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev.med.50.1.223","article-title":"Coagulase-negative staphylococci: role as pathogens","volume":"50","author":"Huebner","year":"1999","journal-title":"Annu Rev Med"},{"key":"10.1111\/j.1469-0691.2008.02663.x_bib2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S1473-3099(02)00438-3","article-title":"Pathogenesis of infections due to coagulase-negative staphylococci","volume":"2","author":"von Eiff","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1111\/j.1469-0691.2008.02663.x_bib3","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMra040181","article-title":"Prosthetic-joint infections","volume":"351","author":"Zimmerli","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2008.02663.x_bib4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1521-6942(03)00002-0","article-title":"Infection and arthritis. Infection of prosthetic joints","volume":"17","author":"Lidgren","year":"2003","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1111\/j.1469-0691.2008.02663.x_bib5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/01.blo.0000072469.32680.b6","article-title":"Revision total hip arthroplasty: hospital cost and reimbursement analysis","volume":"413","author":"Crowe","year":"2003","journal-title":"Clin Orthop Relat Res"},{"key":"10.1111\/j.1469-0691.2008.02663.x_bib6","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/jama.279.19.1575","article-title":"Reconsideration of rifampin: a unique drug for a unique infection","volume":"279","author":"Zavasky","year":"1998","journal-title":"JAMA"},{"key":"10.1111\/j.1469-0691.2008.02663.x_bib7","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1086\/499234","article-title":"Outcome of prosthetic joint infections treated with debridement and retention of components","volume":"42","author":"Marculescu","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2008.02663.x_bib8","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1001\/jama.279.19.1537","article-title":"Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group","volume":"279","author":"Zimmerli","year":"1998","journal-title":"JAMA"},{"key":"10.1111\/j.1469-0691.2008.02663.x_bib9","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1097\/00002480-200011000-00037","article-title":"Role of biofilms in antimicrobial resistance","volume":"46","author":"Donlan","year":"2000","journal-title":"ASAIO J"},{"key":"10.1111\/j.1469-0691.2008.02663.x_bib10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.blo.0000175714.68624.74","article-title":"Biofilms and antimicrobial resistance","volume":"437","author":"Patel","year":"2005","journal-title":"Clin Orthop Relat Res"},{"key":"10.1111\/j.1469-0691.2008.02663.x_bib11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1128\/CMR.15.2.167-193.2002","article-title":"Biofilms: survival mechanisms of clinically relevant microorganisms","volume":"15","author":"Donlan","year":"2002","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/j.1469-0691.2008.02663.x_bib12","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/01.qco.0000235161.85925.e8","article-title":"Infections associated with orthopedic implants","volume":"19","author":"Trampuz","year":"2006","journal-title":"Curr Opin Infect Dis"},{"key":"10.1111\/j.1469-0691.2008.02663.x_bib13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00003086-200508000-00003","article-title":"Biofilm theory can guide the treatment of devicerelated orthopaedic infections","volume":"437","author":"Costerton","year":"2005","journal-title":"Clin Orthop Relat Res"},{"key":"10.1111\/j.1469-0691.2008.02663.x_bib14","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.berh.2006.08.003","article-title":"Infection and musculoskeletal conditions: prosthetic-joint-associated infections","volume":"20","author":"Zimmerli","year":"2006","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1111\/j.1469-0691.2008.02663.x_bib15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1128\/AAC.41.1.107","article-title":"Pharmacodynamic effects of antibiotics and antibiotic combinations on growing and nongrowing Staphylococcus epidermidis cells","volume":"41","author":"Svensson","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2008.02663.x_bib16","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/infdis\/162.1.96","article-title":"Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections","volume":"162","author":"Widmer","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2008.02663.x_bib17","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/jac\/39.2.235","article-title":"Oral treatment of Staphylococcus spp. infected orthopaedic implants with fusidic acid or ofloxacin in combination with rifampicin","volume":"39","author":"Drancourt","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2008.02663.x_bib18","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1469-0691.2006.01463.x","article-title":"Treatment of acute post-surgical infection of joint arthroplasty","volume":"12","author":"Soriano","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2008.02663.x_bib19","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1469-0691.2007.01691.x","article-title":"Treatment of staphylococcal prosthetic joint infections with debridement, prosthesis retention and oral rifampicin and fusidic acid","volume":"13","author":"Aboltins","year":"2007","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2008.02663.x_bib20","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s10096-007-0289-1","article-title":"Efficacy and tolerability of prolonged linezolid therapy in the treatment of orthopedic implant infections","volume":"26","author":"Soriano","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2008.02663.x_bib21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10096-007-0389-y","article-title":"New antimicrobial agents as therapy for resistant gram-positive cocci","volume":"27","author":"Lentino","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2008.02663.x_bib22","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2165\/00003495-200666080-00005","article-title":"Antimicrobial agents in orthopaedic surgery: prophylaxis and treatment","volume":"66","author":"Trampuz","year":"2006","journal-title":"Drugs"},{"key":"10.1111\/j.1469-0691.2008.02663.x_bib23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1365-2672.1978.tb00804.x","article-title":"A simple method for storage of bacteria at \u201376 degrees C","volume":"44","author":"Feltham","year":"1978","journal-title":"J Appl Bacteriol"},{"key":"10.1111\/j.1469-0691.2008.02663.x_bib24","article-title":"Simultaneous species identification and detection of rifampicin resistance in staphylococci by sequencing of the rpoB gene","author":"Hellmark","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2008.02663.x_bib25","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1469-0691.2005.01150.x","article-title":"Predominance of staphylococcal cassette chromosome mec (SCCmec) type IV among methicillin-resistant Staphylococcus aureus (MRSA) in a Swedish county and presence of unknown SCCmec types with Panton\u2013VaIentine leukocidin genes","volume":"11","author":"Berglund","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2008.02663.x_bib26","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1128\/AAC.42.10.2590","article-title":"Characterization of mutations in the rpoB gene that confer rifampin resistance in Staphylococcus aureus","volume":"42","author":"Aubry-Damon","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2008.02663.x_bib27","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1128\/AAC.50.1.298-309.2006","article-title":"Molecular genetic and structural modeling studies of Staphylococcus aureus RNA polymerase and the fitness of rifampin resistance genotypes in relation to clinical prevalence","volume":"50","author":"O\u2019Neill","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2008.02663.x_bib28","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1128\/AAC.43.11.2813","article-title":"Molecular characterization of rpoB mutations conferring cross-resistance to rifamycins on methicillin-resistant Staphylococcus aureus","volume":"43","author":"Wichelhaus","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"issue":"suppl 1","key":"10.1111\/j.1469-0691.2008.02663.x_bib29","doi-asserted-by":"crossref","first-page":"65S","DOI":"10.1093\/jac\/48.suppl_1.65","article-title":"Detection of methicillin\/oxacillin resistance in staphylococci","volume":"48","author":"Brown","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2008.02663.x_bib30","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1136\/jcp.40.10.1178","article-title":"Comparison of culture media for detecting methicillin resistance in Staphylococcus aureus and coagulase negative staphylococci","volume":"40","author":"Milne","year":"1987","journal-title":"J Clin Pathol"},{"key":"10.1111\/j.1469-0691.2008.02663.x_bib31","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/jac\/dkl548","article-title":"Comparison of cefoxitin and moxalactam 30 microg disc diffusion methods for detection of methicillin resistance in coagulase-negative staphylococci","volume":"59","author":"Join-Lambert","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2008.02663.x_bib32","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1469-0691.2005.01230.x","article-title":"Use of rifampicin and ciprofloxacin combination therapy after surgical debridement in the treatment of early manifestation prosthetic joint infections","volume":"11","author":"Berdal","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2008.02663.x_bib33","series-title":"Concise guide to drug interaction principles for medical practice","author":"Cozza","year":"2003"},{"key":"10.1111\/j.1469-0691.2008.02663.x_bib34","series-title":"Martindale: the complete drug reference","author":"Sweetman","year":"2006"},{"key":"10.1111\/j.1469-0691.2008.02663.x_bib35","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1124\/dmd.31.7.878","article-title":"In vitro metabolism of clindamycin in human liver and intestinal microsomes","volume":"31","author":"Wynalda","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1111\/j.1469-0691.2008.02663.x_bib36","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/jac\/dki016","article-title":"Linezolid in the treatment of gram-positive prosthetic joint infections","volume":"55","author":"Bassetti","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2008.02663.x_bib37","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ijantimicag.2007.02.012","article-title":"Daptomycin for treatment of patients with bone and joint infections: a systematic review of the clinical evidence","volume":"30","author":"Falagas","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2008.02663.x_bib38","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1128\/AAC.50.4.1581-1585.2006","article-title":"Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin","volume":"50","author":"Sakoulas","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2008.02663.x_bib39","doi-asserted-by":"crossref","first-page":"5285","DOI":"10.1128\/JCM.43.10.5285-5287.2005","article-title":"Development of daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus","volume":"43","author":"Hayden","year":"2005","journal-title":"J Clin Microbiol"},{"issue":"suppl 2","key":"10.1111\/j.1469-0691.2008.02663.x_bib40","doi-asserted-by":"crossref","first-page":"17S","DOI":"10.1111\/j.1469-0691.2006.01404.x","article-title":"Ceftobiprole: in-vivo profile of a bactericidal cephalosporin","volume":"12","author":"Chambers","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2008.02663.x_bib41","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1586\/14787210.5.4.557","article-title":"Dalbavancin, a long-acting lipoglycopeptide for the treatment of multidrug-resistant Gram-positive bacteria","volume":"5","author":"Decousser","year":"2007","journal-title":"Expert Rev Anti Infect Ther"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X1462142X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X1462142X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T09:05:59Z","timestamp":1558083959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X1462142X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S1198743X1462142X"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2008.02663.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}